| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547724 IAP BIR domain binding compounds |
| 06/16/2009 | US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 06/16/2009 | US7547711 Heterocyclic inhibitors of kinases |
| 06/16/2009 | US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/11/2009 | WO2009073203A1 Trp-m8 receptor ligands and their use in treatments |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009071895A1 Fused thiazole and thiophene derivatives as kinase inhibitors |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071476A1 Isoxazolo-pyridine derivatives |
| 06/11/2009 | WO2009071448A1 Pyridylmethyl-sulfonamide compounds |
| 06/11/2009 | WO2009070869A1 Renin inhibitors |
| 06/11/2009 | WO2009055289A3 Therapeutic substituted lactams |
| 06/11/2009 | WO2008062244A8 Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof |
| 06/11/2009 | WO2002030358A3 Modulation of ccr4 function |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149650 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/11/2009 | US20090149649 Aromatic hetrocyclic compound, organic light-emitting diode including organic layer comprising the aromatic hetrocyclic compound, and method of manufacturing the organic light-emitting diode |
| 06/11/2009 | US20090149517 Novel 2-substituted tiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/11/2009 | US20090149516 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; isomerization of the double bonds in the ring |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149508 Process for the preparation of substituted phenyl ether compounds |
| 06/11/2009 | US20090149471 Monocyclic Heterocyclic Compounds |
| 06/11/2009 | US20090149468 Substituted heterocyclic compounds and methods of use |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149399 Heterocyclic kinase inhibitors |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | CA2707648A1 Isoxazolo-pyridine derivatives |
| 06/11/2009 | CA2707565A1 Renin inhibitors |
| 06/11/2009 | CA2706155A1 Amide compounds as boosters of antivirals |
| 06/11/2009 | CA2705489A1 Pyridylmethyl-sulfonamide compounds |
| 06/10/2009 | EP2067776A1 Piperidine compounds and pharmaceutical compositions containing them |
| 06/10/2009 | EP2066664A1 Heterocyclic organic compounds |
| 06/10/2009 | EP2066637A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 06/10/2009 | EP2066636A1 5-phenyl-nicotinamide derivatives |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP0976737B1 Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101450946A Synthetic method of ziprasidone |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544808 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 06/09/2009 | US7544806 Piperidine-substituted indoles-or heteroderivatives thereof |
| 06/09/2009 | US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544702 Bisaryl-sulfonamides |
| 06/09/2009 | US7544701 Central nervous system disorders; psychological disorders |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544688 Hetereoaryl nitrile derivatives |
| 06/09/2009 | US7544683 Modulation of H3 receptors; obesity; trans-(4-cyclobutyl-piperazin-1-yl)-[4-(4-[1,2,4]triazol-1-yl-phenoxy)-cyclohexyl]-methanone; cis-[4-(6-chloro-pyridin-3-yloxy)-cyclohexyl]-(4-cyclobutyl-piperazin-1-yl)-methanone, |
| 06/09/2009 | US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders |
| 06/09/2009 | US7544681 with organic acids selected to reduce the side effects induced by the psychotropic drugs and/or to exert anti-proliferative activity |
| 06/09/2009 | US7544215 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/04/2009 | WO2009069687A1 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element |
| 06/04/2009 | WO2009068467A1 Aminothiazole derivatives |
| 06/04/2009 | WO2009068214A2 Heteroaryl-substituted piperidines |
| 06/04/2009 | WO2009068170A2 2-(benzyl- and 1h-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
| 06/04/2009 | WO2009051796A3 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 06/04/2009 | WO2009045992A3 C-met protein kinase inhibitors |
| 06/04/2009 | WO2009036068A3 Gambogic amine, a selective trka agonist with neuroprotective activity |
| 06/04/2009 | WO2001060458A3 Inhibitors of prenyl-protein transferase |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143575 Vanilloid receptor ligands and their use in treatments |
| 06/04/2009 | US20090143448 New aminothiazoles as fbpase inhibitors for diabetes |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143413 Thiazole Derivatives as CXCR3 Receptor Modulators |
| 06/04/2009 | US20090143406 New Phenylpiperazine |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143371 Isoxazole-pyridine derivatives |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/04/2009 | US20090143369 Methods of using substituted morpholine and thiomorpholine derivatives |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090143357 Heteroaryl urea derivatives useful for inhibiting chk1 |
| 06/04/2009 | US20090143354 P2X7 Receptor Antagonists and Their Use |
| 06/04/2009 | US20090143353 Antifungal bicyclic hetero ring compounds |
| 06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
| 06/04/2009 | US20090143229 herbicides; protox inhibitors; chemical preparation with m-chloroperoxybenzoic acid;1-(6-chloro-2-mercaptobenzo[d]thiazol-5-yl)-4-(difluoromethyl)-3-methyl-1H-1,2,4-triazol-5(4H)-one |
| 06/04/2009 | CA2707115A1 Chiral 2-(benzylsulfinyl)-thiazole derivatives and 2-[(1h-pyrazol-4-ylmethyl)sulfinyl]-thiazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulators |
| 06/04/2009 | CA2706574A1 Aminothiazole derivatives |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP2065377A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 06/03/2009 | EP2065374A1 2-(benzyl- and 1H-pyrazol-4-ylmethyl)sulfinyl-thiazol-derivatives as herbicides and plant growth regulators |
| 06/03/2009 | EP2065368A1 Inhibitors of IAP |
| 06/03/2009 | EP2065044A1 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 06/03/2009 | EP2064209A1 Pyrrole derivatives with antibacterial activity |
| 06/03/2009 | EP2064208A1 Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function |